“I am pleased to welcome Teresa to our Board of Directors,” said Elisabet de los Pinos, Chief Executive Officer of Aura Biosciences. “She is a seasoned leader whose extensive operational and ...

Climb Bio, Inc. (Nasdaq: CLYM) today announced that members of its executive team will participate at the 24th Annual Needham ...

GENEVA: All 19 of the world's glacier regions experienced a net loss of mass in 2024 for the third consecutive year, the United Nations (UN) said on Friday (Mar 21), warning that saving the ...

Plus Therapeutics shares are trading higher by 244% during Thursday's session. The company announced that the FDA accepted the name REYOBIQ for the company's lead asset. The ‘Trade of the Day ...

The overall quant rating is not an average of the factor grades listed. Instead, it gives greater weight to the metrics with the strongest predictive value.

HOUSTON, March 20, 2025 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (Nasdaq: PSTV) (the “Company”), a clinical-stage pharmaceutical company developing targeted radiotherapeutics with advanced ...

Parisien and Schaffrath said they spent a lot of time looking for the right location for Popovers before they settled on 16 Church St. in Wellesley. They said some landlords would not allow them to ...

The company will henceforth be known as Whitehawk Therapeutics, it announced Tuesday. Its stock ticker will be updated accordingly: As of Wednesday, it will trade as “WHWK” on the Nasdaq ...

WELLESLEY — The appeal of “Better on Paper,” the largest of three new shows at Wellesley College’s Davis Museum, begins with such an expansive show having so terse a title. Five syllables ...

Peptris Technologies, an AI-powered drug discovery company, announced that it has entered into a licensing agreement with Revio Therapeutics, a specialty pharma start-up focused on repurposing and ...